At the end of October - at the beginning of November 2026, the Moscow Arbitration Court accepted three lawsuits by the company "Pharmasil" that owns a registration certificate for intestinal ads Enterosgel (polymethylsiloxane Polyhydrate): "Grotex" (releases products under the Solopharm brand), pharmacy chains "Neop", "offensive chain" by Ozi-Avar, and Avart, "Avart" pharmaceutical company" (Avart), "Avart" of a pharmaceutical company under the brand Solopharm") from the last two operators, the applicant demands to recover 5 million rubles, from other organizations - a total of 68 million rubles. Earlier, Pharmasil addressed the same defendants in a contour of three lawsuits with the demands to stop the infringement of its Eurasian patent on the active substance of Enterosgel and the TK rights. Tag Archives: Vademecum and Vademecum Live.